Concepedia

Publication | Open Access

Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial

DOIFull Paper Access

82

Citations

16

References

2020

Year

RobinKate Kelley, Baek‐Yeol Ryoo, Philippe Merle, Joong‐Won Park, Luigi Bolondi, Stephen L. Chan, Ho-Yeong Lim, Ari David Baron, Francis Parnis, Jennifer J. Knox,
ESMO Open

Abstract

NCT01908426.

References

YearCitations

Page 1